Bristol-Myers Eliquis battles; Indian FRAND rate setting; IAM Global Leaders; Lenovo sues Asus; historic CRISPR drug approval; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.
MONDAY 13 November
Event coverage: Trade secrets, injunctions and AI – the IAM-WTR Latin America IP Summit
FTC challenges 100 patent listings, tightening screws on pharma companies
Data dive: These law firms top the rankings for US patent litigation
Trade secrets: Toy maker sues rival for “brazen” trade secrets theft
TUESDAY 14 November
Chinese patent office hands down key ruling on pharma patent requirements
Bristol-Myers fighting intense battle to keep Eliquis generics off European markets
WEDNESDAY 15 November
Micron targeted by Chinese semiconductor firm in US litigation
Trade secrets: Samsung Display faces off with China’s BOE in ITC trade secrets spat
Weekly column: The EU should listen to its Nordic champions, not ignore them
THURSDAY 16 November
Indian court opens up option for global FRAND rate setting in Nokia-Oppo dispute
Regeneron asserts swathe of patents in latest Eylea biosimilar clash
IAM Global Leaders: AI can super-charge private practice work – but experts warn that there are still considerable risks
Policy: US policymakers wading through stakeholder feedback on patents and technology standards
FRIDAY 17 November
Lenovo sues Asus amid surge of US patent litigation triggered by Chinese companies
Historic CRISPR drug approval heralds new era in Cas9 IP wars
Data dive: Qualcomm leads Brazilian patent filings this year
SATURDAY 18 November
Opinion: IP disclosure requirements are changing – and that is a good thing